Home-monitoring after acute pediatric lung disease

The past years, the use of smartwatches in medical science has increased. Recent systematic reviews have reported studies that used a smartwatch to measure activity level, eating behavior and seizures, among other things. However, these studies are almost always performed on adults and usually in a lab setting. This way of collecting data thus seems to warrant
further validation among children. In the future, CHDR aims to perform clinical trials in pediatric patients using home-monitoring techniques. Clinical research in children is difficult to perform due to the invasive and time-consuming nature of current study protocols. One option to overcome these problems is frequent, non-invasive monitoring of symptoms and disease activity in a home-setting.
CHDR has developed a home-monitoring platform that comprises several devices, one of which is the Nokia Steel HR. This wearable device can monitor physical activity levels, measure pulse rate and analyze sleep pattern and sleep duration. Furthermore, the platform consists of a Nokia thermometer, Nokia scales that can measure weight and body composition and an in-house developed smartphone app that collects and transmits the data, adds a questionnaire function and which can utilize other android phone functions. Several other devices will be added to the platform in the future. In the last year, a pilot study has been performed in the Children’s hospital in Basel, during which the CHDR home-monitoring platform has been improved. Further home-monitoring research, aimed at quantifying disease-activity, will be performed at the Juliana Children’s Hospital in the Hague. Community acquired pneumonia, bronchiolitis,
preschool wheezing and asthma are common diagnoses that are characterized by respiratory complaints and often warrant admission. When patients are stabilized and do not need oxygen therapy, discharge follows swiftly. However, there is very little evidence available on the impact on daily life after discharge and the time till full recovery. In the past, studies have relied on parent-reported recovery via phone interview, but objective data is generally not available. This study aims to investigate this, while also validating the CHDR home-monitoring platform further
to make it suitable for future clinical trials.

The past years, the use of smartwatches in medical science has increased. Recent systematic reviews have reported studies that used a smartwatch to measure activity level, eating behavior and seizures, among other things. However, these studies are almost always performed on adults and usually in a lab setting. This way of collecting data thus seems to warrant further validation among children. In the future, CHDR aims to perform clinical trials in pediatric patients using home-monitoring techniques. Clinical research in children is difficult to perform due to the invasive and time-consuming nature of current trial methods. One option to overcome these problems is frequent, non-invasive monitoring of symptoms and disease activity in a home-setting. For example, by using smartwatches and other devices.

Admission – 14Day recovery period – 25Day break period – 10 day healthy period.